FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057299 [Registered on: 06/09/2023] Trial Registered Prospectively
Last Modified On: 04/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   To compare the pain relief in patients after operation ,with different doses of Dexmedetomidine (a drug )as added drug to Bupivacaine given in spinal anaesthesia & Bupivacaine alone in Open Uterine surgeries  
Scientific Title of Study   Comparative study of the duration of post operative analgesia with different doses of intrathecal Dexmedetomidine as adjuvant to 0.5% Hyperbaric Bupivacaine & with Bupivacaine alone in Total Abdominal Hysterectomy surgeries. - randomized double blind study. 
Trial Acronym  NA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Kavya T 
Designation  Junior resident 
Affiliation  Jubilee Mission Medical College and Research Institute 
Address  Jubilee Mission Medical College and Research Institute ,Department of Anaesthesia and Critical Care Eastfort Trissur Kerala India

Thrissur
KERALA
680005
India 
Phone  8281958073  
Fax    
Email  kavuz57t@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Davies C V 
Designation  Professor 
Affiliation  Jubilee Mission Medical College and Research Institute 
Address  Jubilee Mission Medical College and Research Institute ,Department of Anaesthesia and Critical Care Eastfort Thrissur Kerala INDIA

Thrissur
KERALA
680005
India 
Phone  9387890689  
Fax    
Email  daviescv@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Davies C V 
Designation  Professor  
Affiliation  Jubilee Mission Medical College and Research Institute 
Address  Jubilee Mission Medical College and Research Institute ,Department of Anaesthesia and Critical Care Eastfort Thrissur Kerala India

Thrissur
KERALA
680005
India 
Phone  9387890689  
Fax    
Email  daviescv@gmail.com  
 
Source of Monetary or Material Support  
Jubilee Mission Medical College and Research Institute, Eastfort Thrissur  
 
Primary Sponsor  
Name  Jubilee Mission Medical College and Research Institute 
Address  Jubilee Mission Medical College and Research Institute ,Department of Anaesthesia and Critical Care Eastfort Trissur Kerala India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kavya T  Jubilee Mission Medical College and Research Institute  Diamond Jubilee Block,Room Number 18,Eastfort Thrissur 680005 Kerala
Thrissur
KERALA 
8281958083

kavuz57t@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutionl Ethics Commitee Jubilee Mission Medical College and Research Institute Eastfort Thrissur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N852||Hypertrophy of uterus, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Duration of postoperative analgesia  Duration of post operative analgesia with Dexmedetomidine 5 mcg and 10 mcg in Subarachnoid block as adjuvant to 0.5 % Bupivacaine 
Intervention  Subarachnoid Block  Administration of Subarachnoid Block in Total Abdominal Hysterectomy Surgeries with Dexmedetomidine 5 mcg and 10 mcg as adjuvant to Buoivacaine - 18 months duration of study 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  ASA I & ASA II
PATIENTS SCHEDULED TOTAL ABDOMINAL HYSTERECTOMY  
 
ExclusionCriteria 
Details  Patients with baseline Heart rate < 60 or on Beta blockers / Alpha agonist.
Patient refusal for study participation .
Local infection at injection site.
Presence of any coagulopathies or bleeding disorders or patients on anticoagulation.
PRESENCE OF NEUROLOGICAL DEFICITS, PERIPHERAL NEUROPATHIES, MYOPATHIES, OR CHRONIC PAIN IN THE OPERATING LIMB.
PATIENTS WITH KNOWN ALLERGY TO LOCAL ANAESTHETICS OR TO ANY STUDY DRUGS TO BE USED.
HEMODYNAMICALLY COMPROMISED PATIENTS
ALCOHOLIC/ PSYCHIATRIC/UNCOOPERATIVE PATIENTS
PATIENTS WITH HEPATIC / RENAL OR CARDIOPULMONARY DISORDERS.
PATIENTS LESS THAN 5 FEET HEIGHT.
TOTAL ABDOMINAL HYSTERECTOMY TAKING > 3 HRS.  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Dexmedetomidine 10 mcg was a better adjuvant compared to 5 mcg in terms of better post operative analgesia when used as intrathecal adjuvant to Bupivacaine in subarachnoid block  Post operative analgesia assessed every 6 hours after the requirement of first dose of analgesic  
 
Secondary Outcome  
Outcome  TimePoints 
Onset of sensory block
Onset of motor block
Level of block achieved Duration of sensory block
Duration of motor block  
After administration of subarachnoid block
Onset of block ever 2 minutes
Duration of block every 6 hours
 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   15/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Once completed ,we wish to analyse the data and publish the trial in a pubmed indexed journal  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response (Others) -  All details published will not have patient name

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response (Others) -  All details published will not have patient name
  3. Who will be able to view these files?
    Response (Others) -  All details published will not have patient name

  4. For what types of analyses will this data be available?
    Response (Others) -  All details published will not have patient name

  5. By what mechanism will data be made available?
    Response (Others) -  All details published will not have patient name

  6. For how long will this data be available start date provided 28-02-2025 and end date provided 28-02-2028?
    Response (Others) -  All details published will not have patient name

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary    This study is being undertaken  to evaluate and compare the duration of postoperative analgesia with different doses of intrathecal  Dexmedetomidine , as adjuvant to  Bupivacaine  in Total  Abdominal  Hysterectomy surgeries , and their side effect profile ( As evidenced by Hypotension  and Bradycardia ).Dexmedetomidine 10 mcg was a better adjuvant compared to 5 mcg in terms of better post operative analgesia without increased incidence of side effects  when used as intrathecal adjuvant to Bupivacaine in subarachnoid block  
Close